Tumor tissues were then collected for T cell analysis, as shown in Fig. 9C and Supplementary Fig. 22B-C, the proportion of CD3+T and CD8+T cells in the aCD20@ExoCTX/siPDK4 group (42.78 ± 2.16%) was significantly higher than the other four groups. This evidence concerns the gene CD8A and neoplasm.